Search

Author/Creator Busse, Christopher

2. 02 NEW ONSET AUTOIMMUNE DISORDERS, PRIMARILY PSORIASIS, IN ANTI-TNF BIOLOGIC EXPOSED PEDIATRIC PATIENTS – THE DEVELOP EXPERIENCE. (7th February 2019)

Authors:
Colletti, Richard; Griffiths, Anne; Veereman, Gigi; Escher, Johanna; Izanec, James; Busse, Christopher; Wang, Yanli; Gold, Benjamin
Journal:
Inflammatory bowel diseases
Issue:
Volume 25(2019)Supplement 1
Page Start:
S31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P062 DOSE ESCALATION WITH ORIGINATOR INFLIXIMAB OR COMBINATION THERAPY WITH ORIGINATOR INFLIXIMAB AND IMMUNOMODULATORS SIGNIFICANTLY INCREASES RISK FOR SERIOUS ADVERSE EVENTS IN PEDIATRIC IBD – THE DEVELOP EXPERIENCE. (7th February 2019)

Authors:
Veereman, Gigi; Busse, Christopher; Wang, Yanli; Izanec, James
Journal:
Inflammatory bowel diseases
Issue:
Volume 25(2019)Supplement 1
Page Start:
S29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S1290 Efficacy, Safety, and Pharmacokinetics of Infliximab Dose Escalation in Pediatric Patients With Crohn's Disease or Ulcerative Colitis: An Analysis of the DEVELOP Registry. (October 2021)

Authors:
Dubinsky, Marla C.; Markowitz, James; Busse, Christopher; Koletzko, Sibylle; Winter, Harland; Baldassano, Robert; Colletti, Richard; Kugathasan, Subra; Ruemmele, Frank; Griffiths, Anne; Gasink, Christopher; Adedokun, Omoniyi; Izanec, James L.; Gao, Long-Long; Ma, Tony; Ott, Elyssa; Hyams, Jeffrey
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Page Start:
S592
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗